• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胶质母细胞瘤最大安全切除的有效性,包括老年和低卡诺夫斯基功能状态患者:单机构回顾性研究

Effectiveness of maximal safe resection for glioblastoma including elderly and low Karnofsky performance status patients: retrospective review at a single institute.

作者信息

Uzuka Takeo, Aoki Hiroshi, Natsumeda Manabu, Takahashi Hideaki, Fujii Yukihiko

机构信息

Department of Neurosurgery, Niigata Cancer Center Hospital, Japan.

出版信息

Neurol Med Chir (Tokyo). 2012;52(8):570-6. doi: 10.2176/nmc.52.570.

DOI:10.2176/nmc.52.570
PMID:22976140
Abstract

Elderly and low Karnofsky performance status (KPS) patients have been excluded from most prospective trials. This retrospective study investigated glioblastoma treatment outcomes, including those of elderly and low KPS patients, and analyzed the prognostic factors using the medical records of 107 consecutive patients, 59 men and 48 women aged from 21 to 85 years (median 65 years), with newly diagnosed glioblastoma treated at our institute. There were 71 high-risk patients with age >70 years and/or KPS <70%. Based on the extent of resection, the patients were classified into 3 groups: more than subtotal resection (subtotal, n = 44), partial resection (partial, n = 29), and biopsy only (biopsy, n = 34). Median overall survival (OS) of all 107 patients was 13.5 months. Median OS was 13.2 months in the high-risk group. Median OSs were 15.8, 12.8, and 12.1 months in the subtotal, partial, and biopsy groups, respectively. Multivariate analysis of 73 patients in the subtotal and partial groups found age ≤65 years (p = 0.047), 60 Gy irradiation (p = 0.009), O(6)-methylguanine-deoxyribonucleic acid methyltransferase-negative (p = 0.027), and more than subtotal removal (p = 0.003) were significant prognostic factors. The median postoperative KPS score tended to be better than the preoperative score, even in the high-risk group. We recommend maximal safe resection for glioblastoma patients, even those with advanced age and/or with low KPS scores.

摘要

大多数前瞻性试验都将老年患者和卡氏功能状态评分(KPS)较低的患者排除在外。这项回顾性研究调查了胶质母细胞瘤的治疗结果,包括老年患者和KPS评分较低患者的治疗结果,并利用我院收治的107例连续病例的病历分析了预后因素。这107例患者中,男性59例,女性48例,年龄21至85岁(中位年龄65岁),均为新诊断的胶质母细胞瘤患者。其中有71例高危患者,年龄>70岁和/或KPS<70%。根据切除范围,将患者分为3组:次全切除以上(次全切除,n=44)、部分切除(部分切除,n=29)和仅活检(活检,n=34)。107例患者的中位总生存期(OS)为13.5个月。高危组的中位OS为13.2个月。次全切除组、部分切除组和活检组的中位OS分别为15.8个月、12.8个月和12.1个月。对次全切除组和部分切除组的73例患者进行多因素分析发现,年龄≤65岁(p=0.047)、60 Gy放疗(p=0.009)、O(6)-甲基鸟嘌呤-脱氧核糖核酸甲基转移酶阴性(p=0.027)和次全切除以上(p=0.003)是显著的预后因素。即使在高危组,术后KPS评分中位数也往往优于术前评分。我们建议对胶质母细胞瘤患者进行最大安全切除,即使是高龄和/或KPS评分低的患者。

相似文献

1
Effectiveness of maximal safe resection for glioblastoma including elderly and low Karnofsky performance status patients: retrospective review at a single institute.胶质母细胞瘤最大安全切除的有效性,包括老年和低卡诺夫斯基功能状态患者:单机构回顾性研究
Neurol Med Chir (Tokyo). 2012;52(8):570-6. doi: 10.2176/nmc.52.570.
2
Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.老年胶质母细胞瘤:积极和现代治疗方法对生存的影响。
J Neurosurg. 2016 Apr;124(4):998-1007. doi: 10.3171/2015.4.JNS142200. Epub 2015 Oct 9.
3
Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.就诊于三级医疗机构时 Karnofsky 表现状态评分较低的多形性胶质母细胞瘤患者的治疗结局。临床文章。
J Neurosurg. 2011 Aug;115(2):220-9. doi: 10.3171/2011.3.JNS10495. Epub 2011 May 6.
4
Treatment results and outcome in elderly patients with glioblastoma multiforme--a retrospective single institution analysis.多形性胶质母细胞瘤老年患者的治疗结果与预后——一项单机构回顾性分析
Clin Neurol Neurosurg. 2015 Jan;128:60-9. doi: 10.1016/j.clineuro.2014.11.006. Epub 2014 Nov 15.
5
Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution.在一家三级医疗机构中,接受幕上多形性胶质母细胞瘤根治性手术和放射治疗的老年患者的预后。
Int J Radiat Oncol Biol Phys. 1998 Dec 1;42(5):981-7. doi: 10.1016/s0360-3016(98)00296-x.
6
Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.针对新诊断的多形性胶质母细胞瘤患者,进行有或没有二氟甲基鸟氨酸(DFMO)的加速超分割与有或没有DFMO的标准分割放疗的III期试验。
Int J Radiat Oncol Biol Phys. 2001 Jan 1;49(1):71-7. doi: 10.1016/s0360-3016(00)01458-9.
7
Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.替莫唑胺长期治疗是新诊断胶质母细胞瘤的一种可行选择:一家机构多达101个替莫唑胺疗程的经验。
Neurosurg Focus. 2014 Dec;37(6):E4. doi: 10.3171/2014.9.FOCUS14502.
8
Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.替莫唑胺与放疗同时使用及辅助替莫唑胺治疗的有效性;多形性胶质母细胞瘤的同步治疗:多因素分析及其他预后因素
J Neurosurg Sci. 2010 Mar;54(1):7-19.
9
Hypo-fractionated IMRT for patients with newly diagnosed glioblastoma multiforme: a 6 year single institutional experience.新诊断多形性胶质母细胞瘤患者的低分割调强放疗:六年单机构经验
Clin Neurol Neurosurg. 2013 Sep;115(9):1609-14. doi: 10.1016/j.clineuro.2013.02.001. Epub 2013 Feb 26.
10
Glioblastoma in the elderly: the impact of advanced age on treatment and survival.老年胶质母细胞瘤:高龄对治疗和生存的影响。
J Neurol Surg A Cent Eur Neurosurg. 2014 Jul;75(4):276-81. doi: 10.1055/s-0033-1349713. Epub 2014 Jan 4.

引用本文的文献

1
Surgical Complexity and Complications: The Need for a Common Language.手术复杂性和并发症:需要一种通用语言。
Acta Neurochir Suppl. 2023;130:1-12. doi: 10.1007/978-3-030-12887-6_1.
2
Carmustine wafer implantation for supratentorial glioblastomas, IDH-wildtype in "extreme" neurosurgical conditions.卡莫司汀植入术治疗幕上胶质母细胞瘤,伴 IDH 野生型,在“极端”神经外科条件下。
Neurosurg Rev. 2023 Jun 17;46(1):140. doi: 10.1007/s10143-023-02052-x.
3
Prognostic value of tumour volume in patients with a poor Karnofsky performance status scale - a bicentric retrospective study.
卡氏功能状态评分差的患者肿瘤体积的预后价值 - 一项双中心回顾性研究。
BMC Neurol. 2021 Nov 15;21(1):446. doi: 10.1186/s12883-021-02424-0.
4
The Impact of Perioperative Arterial Infarct on Recurrence, Functional Outcomes, and Survival in Glioblastoma Patients.围手术期动脉梗死对胶质母细胞瘤患者复发、功能结局及生存的影响
Front Oncol. 2020 May 13;10:706. doi: 10.3389/fonc.2020.00706. eCollection 2020.
5
Is a pretreatment radiological staging system feasible for suggesting the optimal extent of resection and predicting prognosis in glioblastoma? An observational study.术前影像学分期系统是否可用于提示胶质母细胞瘤的最佳切除范围并预测预后?一项观察性研究。
J Neurooncol. 2018 Apr;137(2):367-377. doi: 10.1007/s11060-017-2726-z. Epub 2017 Dec 28.
6
Association of the Extent of Resection With Survival in Glioblastoma: A Systematic Review and Meta-analysis.胶质母细胞瘤切除范围与生存的相关性:一项系统评价和荟萃分析。
JAMA Oncol. 2016 Nov 1;2(11):1460-1469. doi: 10.1001/jamaoncol.2016.1373.